1. Exacerbations and remissions of the pain are the general rule.

2. These acute exacerbations frequently follow a head cold , exposure to smoke.

3. Bacterial infections are involved in approximately 50% of acute exacerbations of chronic bronchitis (AECB).

4. Acute exacerbations of chronic bronchitis are always treated with antibiotics effective againstH. influenzae and pneumococci.

5. The results of antibiotic therapy in 271 patients suffering from acute exacerbations of chronic bronchitis are presented.

6. The four most common pathogens of acute exacerbations of chronic bronchitis are pneumococci,Haemophilus influenzae, Moraxella catarrhalis andStaphylococcus aureus.

7. Transtracheal aspirates from 87 patients with acute exacerbations of chronic bronchitis who had received no recent antibiotic treatment were examined.

8. Catarrhalis causes an estimated 2-4 million exacerbations of chronic obstructive pulmonary disease in adults annually in the United States.

9. Discontinuation of Atripla therapy in patients co-infected with HIV and HBV may be associated with severe acute exacerbations of hepatitis

10. The optimal antibiotic and dosage program for the treatment of acute bacterial exacerbations of chronic bronchitis has yet to be defined.

11. Rhinovirus is the most common trigger of exacerbations of asthma, but also has been detected increasingly in doing children with Bronchiolitis

12. Patients with pneumonia and with acute exacerbations of chronic bronchitis were in general given a more conventional duration of therapy.

13. Discontinuation of Truvada therapy in patients co-infected with HIV and HBV may be associated with severe acute exacerbations of hepatitis

14. Serum and sputum concentrations of ampicillin or amoxycillin were measured in patients admitted to hospital for acute exacerbations of chronic bronchitis with purulent sputum.

15. Almost all had been admitted to hospital for acute purulent exacerbations of chronic bronchitis, associated mainly withHaemophilus influenzae, Streptococcus pneumoniae, Branhamella catarrhalis orPseudomonas aeruginosa.

16. AnAerobes have been found in serous effusions and transmeatal biopsies from patients with chronic otitis media and acute exacerbations in the setting of chronic otitis media.

17. Bronchiectasis is a chronic condition where the walls of the bronchi are thickened from inflammation and infection. People with Bronchiectasis have periodic flare-ups of breathing difficulties, called exacerbations.

18. Therefore, the risk-benefit profile of Ketek did not warrant its continued indication for acute bacterial exacerbations of chronic bronchitis, acute bacterial sinusitis and tonsillitis/pharyngitis in patients thirteen years and older.

19. Pustular Bacterid is a skin condition characterized by a symmetric, grouped, vesicular or pustular eruption on the palms and soles marked by exacerbations and remissions over long periods of time.:205

20. Four studies looked at its effects in mild to moderate community-acquired pneumonia, two looked at acute sinusitis, two looked at acute exacerbations of chronic bronchitis and two looked at tonsillitis or pharyngitis

21. Although different Anticholinergics are currently available, ensuring that the patient is receiving the most appropriate therapy and optimizing the pharmacotherapy for the patient based on disease severity are most important to reduce COPD exacerbations, improve …

22. From Wikipedia, the free encyclopedia Pustular Bacterid is a skin condition characterized by a symmetric, grouped, vesicular or pustular eruption on the palms and soles marked by exacerbations and remissions over long periods of time.

23. Moraxella Catarrhalis is the third most common bacterial agent in pediatric acute ear infection. The bacteria are responsible for acute exacerbations of chronic bronchitis and bronchopneumonia in the elderly people and people who lack a good immune system.

24. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (Amazes): a randomised, double-blind, placebo-controlled trial National Health and Medical Research Council of Australia, John Hunter Hospital Charitable Trust.

25. The Committee did not support the continued use of Ketek in the treatment of the remaining three indications - acute bacterial exacerbations of chronic bronchitis, acute bacterial sinusitis and tonsillitis/pharyngitis in patients aged thirteen years and older.

26. One is the presence of mild bronchiectasis with severe emphysema (the patients may suffer from dyspnea and lower exercise tolerance), and the other is a diffuse Bronchiectatic pattern associated with bronchial wall thickening (the patients may present with daily sputum production and frequent exacerbations)

27. The recommendation of the Committee to remove the indications for the treatment of acute bacterial exacerbations of chronic bronchitis, acute bacterial sinusitis and tonsillitis/pharyngitis in patients aged thirteen years and older from the Ketek Product Monograph will be presented to the Division of Anti-Infective Drugs for consideration.

28. At issue is whether, based on the current risk-benefit profile for telithromycin, the drug should continue to be used in the outpatient treatment of adult patients with acute bacterial exacerbations of chronic bronchitis, acute bacterial sinusitis, or for the treatment of pharyngitis/tonsillitis in patients aged thirteen years and older.

29. Moraxella Catarrhalis is a gram-negative, unencapsulated bacterium that frequently colonizes the human nasopharynx (29, 59).This organism is the third-most-common cause of acute otitis media in infants and very young children and can also cause more serious disease in the respiratory tract of adults, likely being responsible for 2 to 4 million exacerbations of chronic obstructive pulmonary